"Butyrates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Salts and esters of butyric acid
MeSH Number(s)
D02.241.081.160.140.135
D10.251.400.241.140.135
Below are MeSH descriptors whose meaning is more general than "Butyrates".
Below are MeSH descriptors whose meaning is more specific than "Butyrates".
This graph shows the total number of publications written about "Butyrates" by people in Harvard Catalyst Profiles by year, and whether "Butyrates" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 2 | 1 | 3 |
| 1993 | 0 | 2 | 2 |
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 3 | 4 |
| 1996 | 2 | 2 | 4 |
| 1997 | 0 | 1 | 1 |
| 1998 | 4 | 2 | 6 |
| 1999 | 4 | 1 | 5 |
| 2000 | 2 | 2 | 4 |
| 2001 | 2 | 3 | 5 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 2 | 1 | 3 |
| 2006 | 7 | 1 | 8 |
| 2007 | 4 | 0 | 4 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 3 | 4 |
| 2010 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 3 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 1 | 3 |
| 2019 | 4 | 0 | 4 |
| 2020 | 5 | 0 | 5 |
| 2021 | 3 | 4 | 7 |
| 2022 | 0 | 2 | 2 |
Below are the most recent publications written about "Butyrates" by people in Profiles.
-
Selective PPARa Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis. Cells. 2022 02 18; 11(4).
-
Strain-level fitness in the gut microbiome is an emergent property of glycans and a single metabolite. Cell. 2022 02 03; 185(3):513-529.e21.
-
Highly Selective PPARa (Peroxisome Proliferator-Activated Receptor a) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging. J Am Heart Assoc. 2021 10 19; 10(20):e020834.
-
In vivo commensal control of Clostridioides difficile virulence. Cell Host Microbe. 2021 11 10; 29(11):1693-1708.e7.
-
The Short-Chain Fatty Acids Propionate and Butyrate Augment Adherent-Invasive Escherichia coli Virulence but Repress Inflammation in a Human Intestinal Enteroid Model of Infection. Microbiol Spectr. 2021 10 31; 9(2):e0136921.
-
Pemafibrate Prevents Retinal Dysfunction in a Mouse Model of Unilateral Common Carotid Artery Occlusion. Int J Mol Sci. 2021 Aug 30; 22(17).
-
Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease. mBio. 2021 08 31; 12(4):e0097521.
-
Prebiotic Supplementation During Pregnancy Modifies the Gut Microbiota and Increases Metabolites in Amniotic Fluid, Driving a Tolerogenic Environment In Utero. Front Immunol. 2021; 12:712614.
-
Colonization of the Caenorhabditis elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate. PLoS Pathog. 2021 05; 17(5):e1009510.
-
Short-chain fatty acid butyrate, a breast milk metabolite, enhances immature intestinal barrier function genes in response to inflammation in vitro and in vivo. Am J Physiol Gastrointest Liver Physiol. 2021 04 01; 320(4):G521-G530.